1. Coexisting psoriasis affects the clinical course of type 1 diabetes in children.
- Author
-
Michalak A, Koptas M, Świercz A, Wyka K, Hogendorf A, Szadkowska A, Młynarski W, and Fendler W
- Subjects
- Adolescent, C-Peptide metabolism, Child, Diabetes Mellitus, Type 1 blood, Female, Humans, Male, Psoriasis blood, C-Peptide blood, Diabetes Mellitus, Type 1 complications, Psoriasis complications
- Abstract
Introduction: Literature reports link psoriasis with insulin resistance characteristic for type 2 diabetes. However, this condition may also affect the clinical course of type 1 diabetes (T1D)., Aim: To investigate whether children with type 1 diabetes mellitus (T1D) and psoriasis have a different course of diabetes., Methods: We evaluated patients diagnosed with T1D in the years 2002-2011 for the presence of psoriasis and matched them 1:10 with T1D-only patients by sex and duration of diabetes using propensity score. We collected T1D-onset parameters and metabolic control surrogates from six months after T1D diagnosis., Results: We identified 14 patients with psoriasis and matched 140 controls, of whom 129 (68 boys) were eligible for the analysis. At onset T1D+psoriasis patients showed higher concentration of C-peptide than controls (median: 0.38ng/ml vs 0.15ng/ml, p=0.02). Six months later, they had non-significantly lower HbA1c (6.0 vs 6.6%, p=0.11), TC (143mg/dl vs 159mg/dl, p=0.14) HDL (54.5mg/dl vs 59mg/dl, p=0.11)., Conclusions: Patients with T1D and psoriasis present higher endogenous insulin secretion at T1D onset and a tendency for better glycemic control during the first 6 months., (© Polish Society for Pediatric Endocrinology and Diabetology.)
- Published
- 2017
- Full Text
- View/download PDF